Clinical trial

Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

NCT01668641

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-05-01

PhasePHASE2

Study timeline

Study start (unknown)2012-05-01Date precision: month

Registry last updated2013-06-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

GLPG0634DRUG

PlaceboDRUG

Sponsors & collaborators

Lakefront Biotherapeutics NVlead sponsor

Mapped research locations

KharkivUkraine3 BudapestHungary2 Saint PetersburgRussia2 MoscowRussia1 YaroslavlRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01668641 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.